Searchable abstracts of presentations at key conferences on calcified tissues
Bone Abstracts (2014) 3 PP374 | DOI: 10.1530/boneabs.3.PP374

Other diseases of bone and mineral metabolism

Clinical presentation of Paget's disease: evaluation of a contemporary cohort and systematic review

Adrian Tan & Stuart Ralston


Rheumatic Diseases Unit, Western General Hospital, Edinburgh, UK.

Background: The prevalence and severity of Paget’s disease of bone (PDB) have fallen over recent years but it is unclear if this has impacted on disease presentation. Here we evaluated the presentation of PDB in a contemporary cohort and conducted a systematic review of MEDLINE on the mode of presentation.

Methods: The presenting features of PDB were recorded in 87 patients who had presented to a specialist clinic between 2005 and 2013. The systematic review was conducted using the MESH terms ‘Paget’s disease of bone’ or ‘osteitis deformans’ and the keyword ‘clinical’. The abstracts of these citations (n=415) were analysed and relevant data extracted.

Results: The incidence of clinically diagnosed PDB in our region was 0.13 cases/10 000 population per year compared with an age-adjusted incidence of 0.70 cases/10 000 per year in the general population. Based on this we estimate that 18% of patients had come to medical attention. Skeletal pain was the presenting feature in 75% of cases but only 36% were thought to have pain caused by PDB. About 5% presented with a pathological fracture; 14% with bone deformity and 1% with deafness. Only 21% of patients were asymptomatic. The patients with bone pain thought to be due to PDB were treated with bisphosphonates and 58% reported an improvement but no tangible improvement was noted in deformity or deafness. The systematic review also showed that bone pain was the most common presenting feature in other case series with variable frequencies of other complications.

Conclusion: Most patients with PDB who come to clinical attention are symptomatic and about 15% have complications by the time they present. Although PDB has become less common in recent years, there remains a clinical need to develop biomarkers for early detection of PDB so that treatment can be initiated before irreversible skeletal damage has occurred.

Volume 3

European Calcified Tissue Society Congress 2014

Prague, Czech Republic
17 May 2014 - 20 May 2014

European Calcified Tissue Society 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts

No recent abstracts.